Former FDA commissioner Scott Gottlieb says FDA is likely to see up to a 25% reviewer exodus over the coming months as about 600 reviewers have currently recused themselves from working on product evaluations while they look for employment outside of the federal government.
HHS secretary Robert F. Kennedy Jr. vows to restore FDA’s and other health agencies’ Freedom of Information Act (FOIA) offices that were gutted earlier this month under White House-mandated staff cuts.
Former FDA commissioner Scott Gottlieb says FDA is likely to see up to a 25% reviewer exodus over the coming months as about 600 reviewers have currently recused themselves from working on product evaluations while they look for employment outside of the federal government.
HHS secretary Robert F. Kennedy Jr. vows to restore FDA’s and other health agencies’ Freedom of Information Act (FOIA) offices that were gutted earlier this month under White House-mandated staff cuts.
A Northern Texas federal judge denies a preliminary injunction sought by Outsourcing Facilities Association to delay FDA enforcement actions against compounding pharmacies that make copies of Novo Nordisk’s semaglutide.
FDA grants Orchestra BioMed a breakthrough device designation for its atrioventricular interval modulation therapy that uses a pacemaker to reduce blood pressure in patients with increased 10-year atherosclerotic cardiovascular disease risk.
